Gross Profit Comparison: Vericel Corporation and HUTCHMED (China) Limited Trends

Biotech Giants' Profit Race: Vericel vs. HUTCHMED

__timestamp	HUTCHMED (China) Limited	Vericel Corporation
Wednesday, January 1, 2014	19764000	11503000
Thursday, January 1, 2015	67426000	24698000
Friday, January 1, 2016	59752000	26076000
Sunday, January 1, 2017	65383000	33570000
Monday, January 1, 2018	70165000	58697000
Tuesday, January 1, 2019	44738000	80279000
Wednesday, January 1, 2020	39457000	84228000
Friday, January 1, 2021	97894000	106025000
Saturday, January 1, 2022	115306000	109788000
Sunday, January 1, 2023	453552000	135576000

Data in motion

A Tale of Two Companies: Vericel Corporation vs. HUTCHMED (China) Limited

In the dynamic world of biotechnology, Vericel Corporation and HUTCHMED (China) Limited have shown intriguing trends in their gross profit over the past decade. From 2014 to 2023, HUTCHMED's gross profit surged by an impressive 2,200%, peaking in 2023. Meanwhile, Vericel's growth was steady, with a notable 1,080% increase over the same period.

Key Insights

2014-2018: Both companies experienced moderate growth, with HUTCHMED leading by a margin of 20-30%.
2019-2021: Vericel closed the gap, achieving a 30% higher gross profit than HUTCHMED in 2021.
2022-2023: HUTCHMED's profits skyrocketed, outpacing Vericel by over 230% in 2023.

These trends highlight the competitive landscape and strategic maneuvers in the biotech sector, offering valuable insights for investors and industry enthusiasts.

Published by

U.S. Securities and Exchange Commission

Source link

sec.gov

Date published

17 Jan 2025

Similar Statistics

Pfizer Inc. and Vericel Corporation: A Detailed Gross Profit Analysis

Amgen Inc. and HUTCHMED (China) Limited: A Detailed Gross Profit Analysis

Sanofi and Vericel Corporation: A Detailed Gross Profit Analysis

Gross Profit Analysis: Comparing Sanofi and HUTCHMED (China) Limited

Takeda Pharmaceutical Company Limited vs Vericel Corporation: A Gross Profit Performance Breakdown

Key Insights on Gross Profit: Biogen Inc. vs Vericel Corporation

Gross Profit Analysis: Comparing BioMarin Pharmaceutical Inc. and Vericel Corporation

Key Insights on Gross Profit: Catalent, Inc. vs HUTCHMED (China) Limited

Gross Profit Comparison: Perrigo Company plc and HUTCHMED (China) Limited Trends

Vericel Corporation or HUTCHMED (China) Limited: Who Leads in Yearly Revenue?

Research and Development Expenses Breakdown: Vericel Corporation vs HUTCHMED (China) Limited

Cost Management Insights: SG&A Expenses for Vericel Corporation and HUTCHMED (China) Limited